AI phone app could spot skin cancer early, trial launches

NCT ID NCT07144306

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether an AI-powered smartphone app (NuvanaDx) can accurately detect skin cancer, including melanoma, by analyzing photos of suspicious moles or lesions. About 100 adults with concerning skin spots will take part. The goal is to see if the app can help catch cancer earlier and reduce wait times for specialist care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nuvana Healthcare Ltd

    RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.